Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Avigen receives FDA approval to continue clinical trials for Coagulin-B gene therapy

Dec. 27, 2001

Phase I trial initiated for antithrombotic drug candidate GH-9001

Dec. 27, 2001

Wyeth-Ayerst and Neose Technologies enter R&D licensing agreement

Dec. 24, 2001

Daiichi patents new series of anticoagulants

Dec. 21, 2001

Aspirin and warfarin equieffective in the prevention of recurrent ischemic stroke

Dec. 21, 2001

Promoters of fibrinolysis designed at Torii as new antithrombotic drugs

Dec. 20, 2001

Approval recommended in E.U. for Arixtra

Dec. 19, 2001

Potent and selective inhibitors of thrombin disclosed by Corvas in recent patent

Dec. 17, 2001

First human study demonstrates safety of heparin/SNAD and potential efficacy

Dec. 14, 2001

Successful repeated administration of MaxAdFVIII achieved in animal studies

Dec. 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.